Tsangs Group Announces the Appointment of Christopher Myers as Director
Tsangs Group is pleased to announce the appointment of Christopher Myers as the Director of the Group, focusing on North American opportunities. Christopher is a seasoned CEO, investor, professor, and author, and he brings a wealth of knowledge and experience to the Group. As a leading global family office , Tsangs Group recognises the vast potential and abundant ……read more
TG Venture Acquisition Corp. Files Presentation About its Pending Business Combination with The Flexi Group, One of APAC’s Largest Operators of Flexible Workspaces
Tsangs Group, as the sponsor, is pleased to provide with the following Press Release. TG Venture Acquisition Corp. (NASDAQ:TGVC) (“TGVC“), a special purpose acquisition company sponsored by Tsangs Group, has filed with the U.S. Securities and Exchange Commission (the “SEC“), as an exhibit to a Current Report on Form 8-K, an investor presentation that relates to its pending ……read more
Tsangs Group Announces the Launch of Hong Kong Ambassadors Club
Tsangs Group, as one of the founding members, is pleased to announce the launch of the Hong Kong Ambassadors Club. Co-founded by the Hon Jeffrey Lam, GBS, JP and Patrick Tsang, the Hong Kong Ambassadors Club (“HKAC”), was officially inaugurated in the Four Seasons Hotel officiated by government officials, consul generals and business magnates, including Mr Christopher Hui, ……read more
Tsangs Group Announces the Launch of Singapore Office and Appointment of Daisy Ha as Chief Executive Officer
Tsangs Group is pleased to announce that we are expanding our branches to South East Asia by launching a new office in Singapore. The new office is located at 12 Marina View, Level 11, Asia Square Tower 2, Singapore 018961. The opening of the new branch marks a new chapter for the Group to explore the abundant potential ……read more
Tsangs Group Announces TECC’s Completion of Acquisition of EDX Medical
Tsangs Group is pleased to announce that, our portfolio company, TECC Capital Plc, now renamed EDX Medical Group, (“the Company”) has completed its acquisition of EDX Medical Limited on 14 November 2022. The Company (TIDM: EDX), which develops digital diagnostic products and services for use in testing for cancer, heart disease, neurology and infectious diseases, announced that 250,833,333 ……read more
Scan QR code to follow our official account on WeChat